Selank is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Selank is administered via intranasal spray at 75-300 mcg 1-3 times daily. Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject Selank?
Selank is administered via intranasal spray. For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Nootropic anxiolytic peptide compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a Selank Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the Selank vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our Selank reconstitution guide.
Step 3: Draw your dose (75-300 mcg) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for Selank): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous Selank injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your Selank Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Selank.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on Selank Injection
Selank is administered via intranasal spray at 75-300 mcg 1-3 times daily. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
Selank: The Anxiolytic Research Peptide
Related Reading
- Selank Dosage Guide
- Selank Benefits
- Selank Side Effects
- Selank Stacking Guide
- Selank Cycle Guide
- Selank Research
Research-Grade Sourcing
If you're going to research Selank, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Selank?
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is a Nootropic anxiolytic peptide. Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) as a benzodiazepine-like anxiolytic without sedation or dependence. It is researched for anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.
What is the recommended Selank dosage?
Common dosages: 75-300 mcg administered 1-3 times daily via intranasal spray. Cycle length: 5-21 days with washout periods. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Selank?
Well-tolerated. Mild nasal irritation at application site. No amnesia, withdrawal, or dependence liability — unlike benzodiazepines.
Is Selank safe?
Selank has shown a favorable safety profile in research. Not FDA-approved. Approved in Russia (2009) for generalized anxiety disorder. Available as research chemical in US. All research should follow appropriate safety protocols.